Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › Cortlandt Manor › NPI 1881659274
Hospital

Hudson Valley Hospital Center

Hudson Valley Hospital Center was paid $15.87M by Medicaid between Jan 2018 and Dec 2024, across 181 billing codes. Its largest line is 99283, emergency room visit (moderate) — 18% of everything it billed.

33Billing provider infoHUDSON VALLEY HOSPITAL CENTER
CORTLANDT MANOR, NY 10567
33aNPI1881659274assigned 04/19/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$15.87M
24GClaims273,476
24DCodes billed181
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in New York

Rank by total paid#68 of 231
Median peer was paid$561K
This provider vs. median28×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20181,288$71K
201920,822$975K
202041,213$2.02M
202155,889$2.99M
202251,418$3.17M
202357,795$3.68M
2024incomplete45,051$2.96M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 18% 15,860 15,119 $2.86M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 13% 12,030 11,554 $2.11M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 9.9% 9,357 8,927 $1.57M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 8.7% 21,264 6,094 $1.39M
96361 Intravenous infusion, hydration; each additional hour 7.9% 4,421 4,191 $1.25M
74177 Computed tomography, abdomen and pelvis; with contrast material 4.4% 2,306 2,274 $701K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 4.2% 6,110 5,961 $659K
70450 Computed tomography, head or brain; without contrast material 4.1% 2,164 2,127 $646K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 3.5% 18,780 5,414 $558K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 3.0% 2,146 1,803 $482K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.8% 2,455 2,399 $447K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 2.4% 526 525 $382K
169 more codes
80053 Comprehensive metabolic panel 2.0% 13,560 $318K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 2.0% 1,545 $310K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.2% 606 $184K
36415 Collection of venous blood by venipuncture 1.1% 18,650 $171K
97161 1.0% 1,371 $162K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 184 $156K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 454 $81K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 343 $72K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,780 $65K
59025 Fetal non-stress test <1% 253 $61K
80076 <1% 2,542 $60K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 2,167 $56K
77067 Screening mammography, bilateral, including computer-aided detection <1% 883 $55K
80048 Basic metabolic panel (calcium, ionized) <1% 3,725 $55K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,429 $55K
86850 <1% 1,239 $54K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 1,308 $50K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 53 $49K
97162 <1% 349 $48K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 989 $45K
88342 <1% 659 $42K
76830 Ultrasound, transvaginal <1% 501 $41K
86900 <1% 1,690 $40K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 154 $38K
12001 <1% 73 $38K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 2,509 $37K
86901 <1% 1,363 $36K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 69 $35K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 838 $31K
76801 <1% 252 $26K
85610 <1% 7,531 $24K
93971 <1% 121 $18K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 6,813 $18K
83880 <1% 612 $18K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 367 $16K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 837 $16K
76641 <1% 578 $14K
29125 <1% 52 $13K
96375 Therapeutic injection; each additional sequential IV push <1% 4,539 $13K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 320 $12K
81025 <1% 3,566 $12K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 49 $10K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 11,346 $8K
70551 Magnetic resonance imaging, brain; without contrast material <1% 24 $8K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 34 $6K
96368 <1% 99 $6K
71046 Radiologic examination, chest; 2 views <1% 1,053 $6K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 5,376 $5K
71045 Radiologic examination, chest; single view <1% 5,076 $5K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed <1% 145 $5K
90715 <1% 167 $4K
93017 <1% 33 $4K
72125 Computed tomography, cervical spine; without contrast material <1% 44 $4K
73030 <1% 449 $4K
84443 Thyroid stimulating hormone (TSH) <1% 639 $4K
73564 <1% 235 $4K
J7030 Infusion, normal saline solution , 1000 cc <1% 3,176 $3K
82803 <1% 112 $3K
29530 <1% 13 $3K
29515 <1% 12 $3K
77063 Screening digital breast tomosynthesis, bilateral <1% 477 $3K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 1,469 $3K
84484 <1% 4,134 $3K
90714 <1% 100 $3K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 56 $2K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 95 $2K
84439 <1% 386 $2K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 12 $2K
85730 <1% 2,423 $2K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 126 $2K
73610 <1% 524 $2K
83036 Hemoglobin; glycosylated (A1C) <1% 239 $2K
88304 <1% 28 $2K
77065 Tomosynthesis, mammo <1% 29 $2K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 13 $2K
73130 <1% 235 $2K
85055 <1% 43 $2K
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,231 $2K
72170 <1% 209 $1K
73630 <1% 379 $1K
83605 <1% 1,229 $1K
81001 <1% 4,772 $1K
83735 <1% 2,937 $1K
80061 Lipid panel <1% 171 $1K
82728 <1% 99 $1K
A9585 Injection, gadobutrol, 0.1 ml <1% 70 $1K
84703 <1% 2,129 $1K
72100 <1% 169 $1K
36591 <1% 35 $951.91
83690 <1% 3,642 $940.05
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 13 $936.73
82248 <1% 1,382 $908.95
82150 <1% 1,514 $892.36
83615 <1% 222 $872.62
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 259 $854.73
76819 Fetal biophysical profile; without non-stress testing <1% 16 $848.30
77080 <1% 12 $806.54
76536 <1% 37 $777.00
85027 <1% 821 $763.67
J7050 Infusion, normal saline solution, 250 cc <1% 533 $718.55
84702 <1% 544 $690.80
87086 Culture, bacterial; quantitative colony count, urine <1% 1,214 $666.64
72114 <1% 29 $626.03
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 991 $585.21
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 3,671 $546.46
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 26 $538.46
73110 <1% 97 $538.09
36416 <1% 35 $479.97
85379 <1% 1,070 $474.31
83540 <1% 95 $471.12
82962 <1% 992 $431.11
83550 <1% 84 $411.28
87081 <1% 1,069 $396.27
96376 <1% 409 $378.18
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,487 $360.71
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 111 $355.47
73562 <1% 115 $329.74
72110 <1% 12 $312.00
82378 <1% 16 $293.27
81003 <1% 1,074 $272.08
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 116 $261.90
87040 <1% 1,014 $259.52
86300 <1% 13 $251.78
82948 <1% 504 $155.54
86140 <1% 101 $151.96
J2274 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg <1% 511 $107.76
85652 <1% 176 $83.44
87070 <1% 770 $80.18
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 70 $61.37
J2704 Injection, propofol, 10 mg <1% 1,375 $52.10
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 3,026 $50.25
73502 <1% 12 $44.88
84100 <1% 120 $39.47
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 24 $33.55
Q9963 High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml <1% 177 $29.78
80299 <1% 73 $29.61
74018 <1% 31 $28.00
80320 <1% 225 $25.25
J7060 5% dextrose/water (500 ml = 1 unit) <1% 18 $24.58
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,227 $19.31
86618 <1% 45 $18.83
J0690 Injection, cefazolin sodium, 500 mg <1% 231 $15.79
J2270 Injection, morphine sulfate, up to 10 mg <1% 271 $14.19
87430 <1% 586 $10.40
73560 <1% 74 $10.10
J1170 Injection, hydromorphone, up to 4 mg <1% 171 $9.73
87077 <1% 32 $9.70
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 674 $7.19
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,051 $6.95
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 189 $6.93
87186 <1% 32 $6.59
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 656 $5.85
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 769 $4.81
J2060 Injection, lorazepam, 2 mg <1% 14 $1.75
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 76 $0.28
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 392 $0.08
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 13 $0.00
99080 0% 303 $0.00
80179 0% 14 $0.00
86753 0% 24 $0.00
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 0% 182 $0.00
82550 0% 66 $0.00
87147 0% 16 $0.00
J0131 Injection, acetaminophen, not otherwise specified,10 mg 0% 64 $0.00
J7644 Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram 0% 74 $0.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 0% 38 $0.00
86617 0% 24 $0.00
G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation 0% 13 $0.00
87205 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialFARRELL, WILLIAM (SENIOR VP, FINANCE)
Same official

Other billing entities under FARRELL, WILLIAM

Full network →
ProviderLocationPaid
The New York and Presbyterian HospitalBronxville, NY$18.84M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.